Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Carr

Showing results (1471-1480 of 1,529) with videos related to

Pageof 153
Sort By:
Journal of Proteome Research|November 20, 2009
Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometryDavid L Tabb, Lorenzo Vega-Montoto, Paul A Rudnick, et al.
Nature Biotechnology|August 21, 2024
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantationNicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, et al.
Journal of Proteome Research|December 15, 2015
Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated XenograftsDavid L Tabb, Xia Wang, Steven A Carr, et al.
Molecular & Cellular Proteomics : MCP|December 4, 2015
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in CancerKelly V Ruggles, Zuojian Tang, Xuya Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active siteS K Thompson, S M Halbert, M J Bossard, et al.
Molecular & Cellular Proteomics : MCP|October 20, 2009
Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analysesPaul A Rudnick, Karl R Clauser, Lisa E Kilpatrick, et al.
Nature|June 3, 2016
Proteogenomics connects somatic mutations to signalling in breast cancerPhilipp Mertins, D R Mani, Kelly V Ruggles, et al.
Cell|August 15, 2023
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulationYifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cancer Discovery|August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Molecular & Cellular Proteomics : MCP|February 20, 2015
Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in PlasmaSusan E Abbatiello, Birgit Schilling, D R Mani, et al.
Pageof 153

Showing results (1471-1480 of 1,529) with videos related to

Sort By:
Pageof 153
Journal of Proteome Research|November 20, 2009
Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometryDavid L Tabb, Lorenzo Vega-Montoto, Paul A Rudnick, et al.
Nature Biotechnology|August 21, 2024
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantationNicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, et al.
Journal of Proteome Research|December 15, 2015
Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated XenograftsDavid L Tabb, Xia Wang, Steven A Carr, et al.
Molecular & Cellular Proteomics : MCP|December 4, 2015
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in CancerKelly V Ruggles, Zuojian Tang, Xuya Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active siteS K Thompson, S M Halbert, M J Bossard, et al.
Molecular & Cellular Proteomics : MCP|October 20, 2009
Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analysesPaul A Rudnick, Karl R Clauser, Lisa E Kilpatrick, et al.
Nature|June 3, 2016
Proteogenomics connects somatic mutations to signalling in breast cancerPhilipp Mertins, D R Mani, Kelly V Ruggles, et al.
Cell|August 15, 2023
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulationYifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cancer Discovery|August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Molecular & Cellular Proteomics : MCP|February 20, 2015
Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in PlasmaSusan E Abbatiello, Birgit Schilling, D R Mani, et al.
Pageof 153